In The News
Bloomberg Law
Zachary L. Baron
In The News
Law360
Sheela Ranganathan
What To Know About ‘Novel’ Johnson & Johnson ERISA Suit
In The News
Tradeoffs
Zachary L. Baron
5 Ways America’s Courts Could Change Health Care in 2024
In The News
The Guardian
Lawrence O. Gostin
Medicare makes opening bid to pharma companies in talks to lower drug costs
In The News
NBC News
Lawrence O. Gostin
Medicare to kick off first drug price negotiations, and it could get heated
In The News
Daily Remedy
In The News
MarketWatch
Zachary L. Baron
Medicare drug price negotiations hit critical phase
In The News
Bloomberg Law
In The News
Bloomberg Law
Zachary L. Baron
Providers Target Insurers in New Surprise Billing Legal Scuffles
In The News
STAT
In The News
Inside Health Policy
Zachary L. Baron
IRA Lawsuits Continue As CMS Approaches Initial Offer Deadline
In The News
Bloomberg Law
Zachary L. Baron
Biden’s Action on Drug Pricing Set for Legal Battles in 2024
In The News
Bloomberg Law
Lawrence O. Gostin
Abortion, Drug Pricing Top Biden List of 2024 Health Challenges
In The News
Fierce Healthcare
Andrew J. Twinamatsiko
2024 Outlook: Drug price negotiations, Braidwood highlights top legal cases to watch
In The News
POLITICO
Zachary L. Baron
DOJ responds to pharma’s IRA tax complaint
Press Release
In The News
Bloomberg Law
Zachary L. Baron
Amgen’s Wezlana Adds Legal Obstacles to Drug Pricing Battle
In The News
Bloomberg Law
Zachary L. Baron
Agencies Will Appeal No Surprises Act Ruling to 5th Circuit
In The News
AIS Health
In The News
Politico
Zachary L. Baron
CMS wants Part D plans to be on their best behavior
In The News
Law360
Zachary L. Baron
Ruling Casts Shadow On Health Plans’ Drug Coupon Policies
In The News
Axios
In The News
Roll Call
Andrew J. Twinamatsiko
Tensions high as Medicare drug negotiations advance
In The News
The Washington Post
Andrew J. Twinamatsiko